This Biotech Startup Thinks It Can Reverse Vision Loss and Cellular Aging. It’s Testing a Novel Therapy Now
The first human patient has received a dose of Life Biosciences’ sight recovery drug.
The first human patient has received a dose of Life Biosciences’ sight recovery drug.